The present invention relates to pharmaceutical suspensions comprising multimeric- multiepitope influenza polypeptides, to processes for their production and to their use as immunizing subjects against influenza. In particular, the invention relates to stable aqueous microparticulate suspensions comprising a multimeric multiepitope polypeptide.